Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib + Pembrolizumab in Head and Neck Cancer
NCT03938337Phase 2Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in head and neck squamous cell carcinoma (HNSCC), sponsored by University of Alabama at Birmingham. Started Oct 2019; status: terminated.
02
Drugs
abemaciclib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03938337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03938337.